Sipai Health Technology Co, Ltd
Sipai Health Technology Co, Ltd operates in the drug retailing industry, providing pharmaceutical and healthcare products to consumers through its retail network.
Business. Sipai Health Technology Co, Ltd (0314.HK) is a drug retailer operating within the Food & Drug Retailing industry. The company is headquartered in China and is primarily listed on the Hong Kong Stock Exchange. It generates revenue through the product-sale model, focusing on the retail distribution of pharmaceutical and health-related products. Specific operating segments and geographic breakdowns are not disclosed in the available data.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Sipai Health Technology Co, Ltd (0314.HK) is a drug retailer operating within the Food & Drug Retailing industry. The company is headquartered in China and is primarily listed on the Hong Kong Stock Exchange. It generates revenue through the product-sale model, focusing on the retail distribution of pharmaceutical and health-related products. Specific operating segments and geographic breakdowns are not disclosed in the available data.
Sipai Health Technology Co, Ltd has a fully diluted share count of 735,798,314 shares, with no difference between basic and diluted shares outstanding, indicating no dilution from stock options or convertible securities. The company's liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.
The company reported a revenue of 4.71 billion CNY in the latest period, but it also reported a negative EPS of -0.40 CNY, indicating a loss per share. This loss per share suggests that the company is not currently generating profits, which is a concern for investors. The company's profitability metrics, such as net margin and return on equity, are not available, making it difficult to assess its financial performance relative to industry standards.
Sipai Health Technology Co, Ltd's revenue is concentrated in a single business segment, as disclosed in its financial reports, with no geographic breakdown provided. This lack of geographic diversification could expose the company to regional economic or regulatory risks.
The company's growth trajectory is uncertain, as there are no forward-looking revenue projections or outlooks provided in the available data. The absence of analyst estimates for future performance makes it difficult to assess the company's potential for growth or recovery.
The company's risk profile is characterized by low dilution potential and an inability to assess liquidity risk due to missing balance-sheet data. The absence of going-concern language in source documents suggests that the company is not currently under immediate financial distress, but the lack of liquidity data is a red flag for investors.
Recent events and filings do not provide additional insight into the company's operations or financial health. The absence of recent earnings calls, investor presentations, or regulatory filings beyond the basic financial snapshot limits the ability to assess the company's strategic direction or management commentary.
- Sipai Health Technology Co, Ltd has no difference between basic and diluted shares outstanding, indicating no dilution from stock options or convertible securities.
- The company reported a negative EPS of -0.40 CNY, indicating a loss per share.
- Revenue is concentrated in a single business segment, with no geographic diversification disclosed.
- Growth trajectory is uncertain due to the absence of forward-looking revenue projections.
- Liquidity risk could not be assessed due to missing balance-sheet data and no going-concern language in source documents.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Revenue ¥2.07B, −54,6% YoY; Operating income +64,6% YoY.
- ▍Revenue ¥2.07B, −54,6% YoY
- ▍Operating income +64,6% YoY
- ▍Net income +61,6% YoY
- ▍Free cash flow +67,2% YoY
- ▍Net margin -6.0%
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Sipai Health Technology Co, Ltd Market data — financials · 2026-05-26
- Sipai Health Technology Co, Ltd Market data — analyst estimates · 2026-05-26